1 |
Goldman BS, Joison J, Austen WG. Cardiovascular effects of protamine sulfate. Ann Thora Surg 1969; 7: 459-471.
DOI
|
2 |
Horrow JC. Protamine: a review of its toxicity. Anesth Analg 1985; 64: 348-361.
|
3 |
Jaques LB. A study of the toxicity of the protamine, salmine. Br J Pharmacol Chemother 1949; 4: 135-144.
DOI
|
4 |
Kambam J, Meszaros R, Merrill W, Stewart J, Smith BE, Bender H. Prophylactic administration of histamine 1 and histamine 2 receptor blockers in the prevention of protaminerelated haemodynamic effects. Can J Anesth 1990; 37: 420-422.
DOI
|
5 |
Li J, Hajarizadeh H, La Rosa C, Rohrer M, Vander Salm TJ, Cutler B. Heparin and protamine stimulate the production of nitric oxide. J Cardiovasc Surg (Torino) 1996; 37: 445-452.
|
6 |
Mayumi H, Toshima Y, Tokunaga K. Pretreatment with H2 blocker famotidine to ameliorate protamine-induced hypotension in open-heart surgery. J Cardiovasc Surg 1992; 33: 738-745.
|
7 |
Porsche R, Brenner ZR. Allergy to protamine sulfate. Heart Lung 1999; 28: 418-428.
DOI
|
8 |
Ransdell HT, Haller JA, Stowens D, Barton PB. Renal toxicity of polybrene (hexadimethrine bromide). J Surg Res 1965; 5: 195-199.
DOI
|
9 |
Wakefield T, Lindblad B, Whitehouse Jr W, Hantler C, Stanley J. Attenuation of hemodynamic and hematologic effects of heparin-protamine sulfate interaction after aortic reconstruction in a canine model. Surgery 1986; 100: 45-51.
|
10 |
Wakefield TW, Ucros I, Kresowik TF, Hinshaw DB, Stanley JC. Decreased oxygen consumption as a toxic manifestation of protamine sulfate reversal of heparin anticoagulation. J Vasc Surg 1989; 9: 772-777.
DOI
|
11 |
Yoo KY, Rim SJ, Shim SJ, Chung SS, Im WM. Mechanism of the Hypotension Produced Protamine Sulfate in Dogs. Korean J Anesthesiol 1998; 34: 27-38.
DOI
|
12 |
Ching KS, Leong DS. Cardiopulmonary effects of protamine in man. Anesthesiology 1980; 53: S116.
DOI
|
13 |
Adkins JR, Hardy JD. Sodium heparin neutralization and the anticoagulant effects of protamine sulfate. Arch Surg 1967; 94: 175-177.
DOI
|
14 |
Carr J, Silverman N. The heparin-protamine interaction: a review. J Cardiovasc Surg 1999; 40: 659.
|
15 |
Chang L-C, Wrobleski S, Wakefield TW, Lee LM, Yang VC. Low molecular weight protamine as nontoxic heparin/low molecular weight heparin antidote (III): preliminary in vivo evaluation of efficacy and toxicity using a canine model. AAPS PharmSci 2001; 3: 24-31.
DOI
|
16 |
Eika C. On the mechanism of platelet aggregation induced by heparin, protamine and polybrene. Scand J Haematol 1972; 9: 248-257.
|
17 |
Fadali MA, Ledbetter M, Papacostas CA, Duke LJ, Lemole GM. Mechanism responsible for the cardiovascular depressant effect of protamine sulfate. Ann Surg 1974; 180: 232-235.
DOI
|
18 |
Frater R, Oka Y, Hong Y, Tsubo T, Loubser P, Masone R. Protamine-induced circulatory changes. J Thorac Cardiovasc Surg 1984; 87: 687-692.
|